Rohto Pharmaceutical plans to acquire 790,600 shares, equivalent to 51% of voting rights, of Thai wellness company Thann Oryza Co., Ltd., making it a subsidiary. The share transfer is scheduled for March 31, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4527","jir_company_name":"Rohto Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-01-07","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/4527-20260107-01.pdf","jir_short_summary":"Rohto Pharmaceutical plans to acquire 790,600 shares, equivalent to 51% of voting rights, of Thai wellness company Thann Oryza Co., Ltd., making it a subsidiary. The share transfer is scheduled for March 31, 2026.","jir_summary":"### Overview of the M&A\nRohto Pharmaceutical Co., Ltd. resolved at the Board of Directors meeting on January 7, 2026, to acquire shares of Thai wellness company Thann Oryza Co., Ltd., headquartered in Bangkok, Thailand, thereby making it a subsidiary. The number of shares to be acquired is 790,600 shares, equivalent to 51% of the voting rights, and the share transfer execution date is scheduled for March 31, 2026. Thann operates natural skincare and lifestyle brands and conducts business in 14 countries mainly across Asia, holding strong recognition in the premium spa and wellness sectors.\n\n### Future Outlook and Impact\nThrough this share acquisition, Rohto Pharmaceutical intends to leverage Thann's brand assets and customer base to pursue growth opportunities in the global market. Goodwill is expected to arise from the acquisition; however, the impact on consolidated earnings is anticipated to be minor. The acquisition price remains undisclosed due to confidentiality obligations. Thann's recent financial results for the fiscal year ending December 2024 show sales of 382.9 million THB, with operating loss and net loss, and performance improvement is expected going forward.","jir_financial_highlights":"Number of Shares Acquired: 790,600 shares (Equivalent to 51% of voting rights)\nAcquisition Price: Undisclosed (Unknown)\nThann Oryza Co., Ltd. Sales (Fiscal Year Ending December 2024): 382.9 million THB (Decreased Year-over-Year (previous year: 438.0 million THB))\nThann Oryza Co., Ltd. Operating Income (Fiscal Year Ending December 2024): (8.8) million THB (Deteriorated Year-over-Year (previous year: 15.5 million THB))\nThann Oryza Co., Ltd. Net Income Attributable to Owners of Parent (Fiscal Year Ending December 2024): (8.9) million THB (Deteriorated Year-over-Year (previous year: 12.1 million THB))","jir_category":"","jir_hashtags":"#RohtoPharmaceutical, #M&A, #Wellness","jir_key_figures":"Number of Shares Acquired: 790,600 shares (equivalent to 51% of voting rights)\nShare Transfer Execution Date: March 31, 2026 (scheduled)\nThann Sales for Fiscal Year Ending December 2024: 382.9 million THB (previous year: 438.0 million THB)","jir_meta_title":"Rohto Pharmaceutical Resolves to Acquire 51% Stake in Thai Wellness Company Thann","jir_meta_description":"Rohto Pharmaceutical plans to acquire shares equivalent to 51% of voting rights in Thai wellness company Thann Oryza Co., Ltd., making it a subsidiary. The share transfer is scheduled for March 31, 2026, accelerating growth opportunities in the global market.","jir_og_title":"Rohto Pharmaceutical Acquires 51% Stake in Thai Wellness Company Thann","jir_og_description":"Rohto Pharmaceutical acquires 51% of shares in Thai wellness company Thann, making it a subsidiary. Leveraging brand assets to aim for global growth.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7770,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"m_and_a_alliance","footnotes":""},"sector":[],"importance":[],"class_list":["post-15202","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n